These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23883125)

  • 21. Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers.
    Shrestha N; Shahbazi MA; Araújo F; Zhang H; Mäkilä EM; Kauppila J; Sarmento B; Salonen JJ; Hirvonen JT; Santos HA
    Biomaterials; 2014 Aug; 35(25):7172-9. PubMed ID: 24844163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo biocompatibility of porous silicon biomaterials for drug delivery to the heart.
    Tölli MA; Ferreira MP; Kinnunen SM; Rysä J; Mäkilä EM; Szabó Z; Serpi RE; Ohukainen PJ; Välimäki MJ; Correia AM; Salonen JJ; Hirvonen JT; Ruskoaho HJ; Santos HA
    Biomaterials; 2014 Sep; 35(29):8394-405. PubMed ID: 24985734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy.
    Li W; Liu Z; Fontana F; Ding Y; Liu D; Hirvonen JT; Santos HA
    Adv Mater; 2018 Jun; 30(24):e1703740. PubMed ID: 29534311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional hydrophobin-coating of thermally hydrocarbonized porous silicon microparticles.
    Bimbo LM; Mäkilä E; Raula J; Laaksonen T; Laaksonen P; Strommer K; Kauppinen EI; Salonen J; Linder MB; Hirvonen J; Santos HA
    Biomaterials; 2011 Dec; 32(34):9089-99. PubMed ID: 21864895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fabrication and Characterization of a Porous Silicon Drug Delivery System with an Initiated Chemical Vapor Deposition Temperature-Responsive Coating.
    McInnes SJ; Szili EJ; Al-Bataineh SA; Vasani RB; Xu J; Alf ME; Gleason KK; Short RD; Voelcker NH
    Langmuir; 2016 Jan; 32(1):301-8. PubMed ID: 26654169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanostructured porous silicon-mediated drug delivery.
    Martín-Palma RJ; Hernández-Montelongo J; Torres-Costa V; Manso-Silván M; Muñoz-Noval Á
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1273-83. PubMed ID: 24941438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxicity assessment of porous silicon microparticles for ocular drug delivery.
    Korhonen E; Rönkkö S; Hillebrand S; Riikonen J; Xu W; Järvinen K; Lehto VP; Kauppinen A
    Eur J Pharm Biopharm; 2016 Mar; 100():1-8. PubMed ID: 26686646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amine modification of thermally carbonized porous silicon with silane coupling chemistry.
    Mäkilä E; Bimbo LM; Kaasalainen M; Herranz B; Airaksinen AJ; Heinonen M; Kukk E; Hirvonen J; Santos HA; Salonen J
    Langmuir; 2012 Oct; 28(39):14045-54. PubMed ID: 22967052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porous silicon-cell penetrating peptide hybrid nanocarrier for intracellular delivery of oligonucleotides.
    Rytkönen J; Arukuusk P; Xu W; Kurrikoff K; Langel U; Lehto VP; Närvänen A
    Mol Pharm; 2014 Feb; 11(2):382-90. PubMed ID: 24341621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of iCVD and porous silicon for the development of a controlled drug delivery system.
    McInnes SJ; Szili EJ; Al-Bataineh SA; Xu J; Alf ME; Gleason KK; Short RD; Voelcker NH
    ACS Appl Mater Interfaces; 2012 Jul; 4(7):3566-74. PubMed ID: 22720638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New times, new trends for ethionamide: In vitro evaluation of drug-loaded thermally carbonized porous silicon microparticles.
    Vale N; Mäkilä E; Salonen J; Gomes P; Hirvonen J; Santos HA
    Eur J Pharm Biopharm; 2012 Jun; 81(2):314-23. PubMed ID: 22418076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The photophysics of porous silicon: technological and biomedical implications.
    Kotkovskiy GE; Kuzishchin YA; Martynov IL; Chistyakov AA; Nabiev I
    Phys Chem Chem Phys; 2012 Oct; 14(40):13890-902. PubMed ID: 22968392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications.
    Santos HA; Mäkilä E; Airaksinen AJ; Bimbo LM; Hirvonen J
    Nanomedicine (Lond); 2014 Apr; 9(4):535-54. PubMed ID: 24787441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlling and Predicting the Dissolution Kinetics of Thermally Oxidised Mesoporous Silicon Particles: Towards Improved Drug Delivery.
    Wang F; Barnes TJ; Prestidge CA
    Pharmaceutics; 2019 Nov; 11(12):. PubMed ID: 31795166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biosensing and protein fluorescence enhancement by functionalized porous silicon devices.
    Palestino G; Agarwal V; Aulombard R; Pérez E; Gergely C
    Langmuir; 2008 Dec; 24(23):13765-71. PubMed ID: 18959435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Porous silicon-based sensing and delivery platforms for wound management applications.
    Duan W; Zhao J; Gao Y; Xu K; Huang S; Zeng L; Shen JW; Zheng Y; Wu J
    J Control Release; 2024 Jul; 371():530-554. PubMed ID: 38857787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles.
    Liu D; Bimbo LM; Mäkilä E; Villanova F; Kaasalainen M; Herranz-Blanco B; Caramella CM; Lehto VP; Salonen J; Herzig KH; Hirvonen J; Santos HA
    J Control Release; 2013 Sep; 170(2):268-78. PubMed ID: 23756152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular interactions of surface modified nanoporous silicon particles.
    Bimbo LM; Sarparanta M; Mäkilä E; Laaksonen T; Laaksonen P; Salonen J; Linder MB; Hirvonen J; Airaksinen AJ; Santos HA
    Nanoscale; 2012 May; 4(10):3184-92. PubMed ID: 22508528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mathematical modeling of drug release from nanostructured porous Si: combining carrier erosion and hindered drug diffusion for predicting release kinetics.
    Tzur-Balter A; Young JM; Bonanno-Young LM; Segal E
    Acta Biomater; 2013 Sep; 9(9):8346-53. PubMed ID: 23770226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macroporous silicon templated from silicon nanocrystallite and functionalized Si-H reactive group for grafting organic monolayer.
    Guo DJ; Wang J; Tan W; Xiao SJ; Dai ZD
    J Colloid Interface Sci; 2009 Aug; 336(2):723-9. PubMed ID: 19446831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.